Cytek Biosciences (CTKB) Other Non Operating Income (2020 - 2026)

Cytek Biosciences' Other Non Operating Income history runs 7 years deep, the most recent figure standing at $565000.0 for Q1 2026.

• Quarterly Other Non Operating Income fell 83.82% year-over-year to $565000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.9 million (down 17.64% YoY) and the FY2025 annual result came in at $8.8 million, up 97.2% from the prior year.
• Other Non Operating Income was $565000.0 for Q1 2026 at Cytek Biosciences, up from $258000.0 in the prior quarter.
• Across five years, Other Non Operating Income topped out at $3.7 million in Q2 2025 and bottomed at -$445000.0 in Q3 2022.
• A 5-year average of $1.3 million and a median of $1.2 million in 2023 frame the typical range for Other Non Operating Income.
• Annual changes were most pronounced in 2022 — Other Non Operating Income slumped 111.67% — and 2025, when it jumped 6184.75%.
• Cytek Biosciences' Other Non Operating Income stood at $2.1 million in 2022, then surged by 52.75% to $3.2 million in 2023, then tumbled by 84.63% to $491000.0 in 2024, then sank by 47.45% to $258000.0 in 2025, then surged by 118.99% to $565000.0 in 2026.
• Business Quant data shows CTKB's Other Non Operating Income at $565000.0 in Q1 2026, $258000.0 in Q4 2025, and $1.3 million in Q3 2025.